A carregar...
TRTH-01. PRECLINICAL ACTIVITY OF TEMOZOLOMIDE WITH MORPHINE COMBINATION IN THE THERAPY OF GLIOBLASTOMA MULTIFORME
Despite concurrent temozolomide (TMZ) and radiation therapy, the prognosis of glioblastoma multiforme (GBM) is about 14.6 months and two-year survival is 30%. On the basis of the pharmacological modulation of Blood-Brain Barrier permeability, we have evaluated the effect of combined treatment, TMZ p...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475180/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.213 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|